Adirondack Trust Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Sell |
400
-51
| -11% | -$26.8K | 0.08% | 133 |
|
|
2025
Q1 | $286K | Buy |
451
+18
| +4% | +$11.4K | 0.11% | 118 |
|
|
2024
Q4 | $308K | Buy |
433
+2
| +0.5% | +$1.43K | 0.12% | 113 |
|
|
2024
Q3 | $453K | Buy |
431
+10
| +2% | +$10.5K | 0.17% | 99 |
|
|
2024
Q2 | $442K | Sell |
421
-1
| -0.2% | -$1.05K | 0.18% | 97 |
|
|
2024
Q1 | $406K | Sell |
422
-16
| -4% | -$15.4K | 0.17% | 102 |
|
|
2023
Q4 | $423K | Sell |
438
-22
| -5% | -$21.3K | 0.18% | 96 |
|
|
2023
Q3 | $379K | Hold |
460
| – | – | 0.19% | 90 |
|
|
2023
Q2 | $341K | Sell |
460
-10
| -2% | -$7.42K | 0.16% | 108 |
|
|
2023
Q1 | $386K | Sell |
470
-7
| -1% | -$5.75K | 0.2% | 96 |
|
|
2022
Q4 | $344K | Hold |
477
| – | – | 0.18% | 106 |
|
|
2022
Q3 | $329K | Buy |
477
+27
| +6% | +$18.6K | 0.18% | 99 |
|
|
2022
Q2 | $266K | Buy |
450
+57
| +15% | +$33.7K | 0.14% | 104 |
|
|
2022
Q1 | $274K | Buy |
393
+127
| +48% | +$88.5K | 0.13% | 106 |
|
|
2021
Q4 | $168K | Buy |
266
+4
| +2% | +$2.53K | 0.08% | 127 |
|
|
2021
Q3 | $168K | Buy |
262
+11
| +4% | +$7.05K | 0.08% | 127 |
|
|
2021
Q2 | $140K | Hold |
251
| – | – | 0.07% | 133 |
|
|
2021
Q1 | $119K | Buy |
251
+140
| +126% | +$66.4K | 0.06% | 139 |
|
|
2020
Q4 | $56K | Buy |
111
+3
| +3% | +$1.51K | 0.03% | 164 |
|
|
2020
Q3 | $60K | Hold |
108
| – | – | 0.04% | 156 |
|
|
2020
Q2 | $68K | Hold |
108
| – | – | 0.05% | 152 |
|
|
2020
Q1 | $53K | Buy |
108
+5
| +5% | +$2.45K | 0.04% | 149 |
|
|
2019
Q4 | $35K | Sell |
103
-28
| -21% | -$9.52K | 0.02% | 189 |
|
|
2019
Q3 | $36K | Hold |
131
| – | – | 0.03% | 182 |
|
|
2019
Q2 | $41K | Hold |
131
| – | – | 0.03% | 179 |
|
|
2019
Q1 | $45K | Hold |
131
| – | – | 0.03% | 166 |
|
|
2018
Q4 | $49K | Sell |
131
-9
| -6% | -$3.37K | 0.04% | 158 |
|
|
2018
Q3 | $57K | Buy |
140
+5
| +4% | +$2.04K | 0.04% | 160 |
|
|
2018
Q2 | $47K | Hold |
135
| – | – | 0.03% | 163 |
|
|
2018
Q1 | $41K | Buy |
135
+35
| +35% | +$10.6K | 0.03% | 167 |
|
|
2017
Q4 | $38K | Hold |
100
| – | – | 0.03% | 166 |
|
|
2017
Q3 | $45K | Hold |
100
| – | – | 0.04% | 160 |
|
|
2017
Q2 | $49K | Sell |
100
-15
| -13% | -$7.35K | 0.04% | 157 |
|
|
2017
Q1 | $45K | Sell |
115
-55
| -32% | -$21.5K | 0.03% | 165 |
|
|
2016
Q4 | $62K | Hold |
170
| – | – | 0.04% | 150 |
|
|
2016
Q3 | $68K | Buy |
170
+55
| +48% | +$22K | 0.05% | 149 |
|
|
2016
Q2 | $40K | Hold |
115
| – | – | 0.03% | 192 |
|
|
2016
Q1 | $41K | Hold |
115
| – | – | 0.03% | 172 |
|
|
2015
Q4 | $48K | Sell |
115
-5
| -4% | -$2.09K | 0.04% | 159 |
|
|
2015
Q3 | $56K | Buy |
120
+5
| +4% | +$2.33K | 0.05% | 143 |
|
|
2015
Q2 | $59K | Buy |
115
+5
| +5% | +$2.57K | 0.04% | 148 |
|
|
2015
Q1 | $50K | Buy |
110
+5
| +5% | +$2.27K | 0.04% | 160 |
|
|
2014
Q4 | $43K | Buy |
105
+5
| +5% | +$2.05K | 0.03% | 167 |
|
|
2014
Q3 | $36K | Buy |
100
+10
| +11% | +$3.6K | 0.03% | 172 |
|
|
2014
Q2 | $25K | Buy |
90
+40
| +80% | +$11.1K | 0.02% | 195 |
|
|
2014
Q1 | $15K | Buy |
+50
| New | +$15K | 0.01% | 213 |
|